| Old Articles: <Older 48601-48610 Newer> |
|---|
 |
The Motley Fool
May 12, 2011
Brian Orelli |
ViroPharma Gives It a Shot Testing a subcutaneous form of Cinryze.   |
The Motley Fool
May 12, 2011
Rich Smith |
Force Protection and the War on Terrorized Defense Investors Osama bin Laden is still dead. Is the defense industry dead, too? |
The Motley Fool
May 12, 2011
Rich Smith |
American Science and Bad Forecasting Wall Street can't get this one right -- don't you make the same mistake. |
The Motley Fool
May 12, 2011
Anupama Pattanaik |
Aegean's Voyage to Panama Aegean to expand its business in the ports of Panama. |
The Motley Fool
May 12, 2011
Andrew Tonner |
Does Sysco Deserve a Spot in Your Portfolio? A quick check of their numbers should help get us started. |
The Motley Fool
May 12, 2011
Christopher Barker |
Gammon Basks in the Glow of Silver and Gold Whether viewed through a gold or silver lens, Gammon stacks-up against its rivals |
The Motley Fool
May 12, 2011
Jim Royal |
Profit From This Energy Paradox The place to be for the long term is oil and gas stocks. |
The Motley Fool
May 12, 2011
Zeeshan Siddique |
With AirTran in Its Arsenal, Southwest Airlines Turns Skyward After absorbing a key rival, the low-fare airline has blue skies ahead. |
The Motley Fool
May 12, 2011
David Holding |
BT Dials Up Some Impressive Numbers. Where Next for the Shares? This FTSE stalwart is up big over the past 48 months. |
The Motley Fool
May 12, 2011
Sean Williams |
4 Large-Cap Single-Digit P/Es You Can Trust These large-cap names could provide surprising value and stability to your portfolio. |
| <Older 48601-48610 Newer> Return to current articles. |
